ArticleJournal of orthopaedic translation2026
Role of collagen VI and IX in mechanotransduction in the cartilage microenvironments: A multiscale in silico examination.
Article in Journal of orthopaedic translation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging mechanisms and translational advances in musculoskeletal diseases.Journal of orthopaedic translation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background/objectives: Chondrocytes are mechanosensitive cells involved in the biosynthesis and maintenance of articular cartilage. Histologically, these cells are surrounded by a pericellular matrix (PCM) characterized by a relatively high concentration of collagen VI and a low concentration of collagen IX in the junction area with the extracellular matrix (ECM). However, the impact of PCM composition and its interaction with the ECM, such as alteration of collagen content (VI, IX), on chondrocyte mechanics is largely unknown. This study aimed to develop a multiscale model to investigate the role of collagens VI and IX in regulating cellular and tissue-level cartilage mechanics. Methods: A poro-hyperelastic multi-scale finite element cartilage model was developed to connect aggregate tissue-level load to cellular mechanics. The cell-enriched cartilage model included anatomical cell distributions and collagen types II, VI, and IX, representing the building block network of the ECM and PCM, respectively. An unconfined compression test was simulated under normal and perturbed collagen VI and IX nonlinear properties. Cellular- and tissue-level mechanics were simulated simultaneously using an explicit coupling approach. Results: At the aggregate level, cartilage reaction force varied substantially with alteration of collagen VI, while it was largely unaffected by changes in collagen IX properties within the range of variations considered. Furthermore, alterations in collagen VI and IX stiffness were associated with changes in cellular volume, supported load, and the mechanical microenvironment of the cells. Conclusion: These findings indicate that minor collagen networks can modulate the cellular mechanical environment while exerting a limited effect on the macroscopic cartilage response. Delineating this association will likely improve understanding of cellular function under conditions in which collagens VI and IX are compromised, such as focal injuries or enzymatic degradation. Translational potential statement: This study demonstrates that alterations in minor collagen networks (types VI and IX) can modulate chondrocyte mechanotransduction, positioning them as potential mechanobiological markers in understanding the onset and progression of degenerative joint diseases such as osteoarthritis. The realistic multiscale cartilage model offers a physiologically relevant framework that, when integrated with joint-level simulations, could predict cell-level loading during daily physical activities-informing diagnostics, therapeutic strategies, and biomaterial design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.